The term incorporates the scientific fields of nutrition and dietetics primarily. Clinical nutrition aims to keep a sufficient energy balance in patients by providing an adequate amount of other nutrients such as protein, vitamins, minerals, etc.,
The introduction of real food clinical nutrition products and expansion of distribution network.
For instance, in June 2018, Functional Formularies, a pioneer of healthy food alternatives have started an exclusive distribution partnership with Bowers Medical Supply which makes Liquid Hope and Nourish, these products are nutritionally complete whole food feeding formula without the added sugars, fruit-based sweeteners, additives or stabilizers found in other methods. Accessible to the Canadian market. Created using the Food as Medicine model and approved by Health Canada.
Increase in some premature babies has driven the global Clinical Nutrition market.
According to the World health organization (WHO), an estimated 15 million babies are born preterm each year, and the number is expected to rise in the coming years.
According to WHO, across 184 countries, the rate of preterm birth ranges from 5% to 18% of babies born, more than 60% of preterm births occur in Africa and South Asia.
In 2017, the U.S preterm birth rate has increased by 10%.
According to the National Institute for Health and Welfare, out of 1,000 premature infants, 44 die before the age of one, due to insufficient nutrients to the infants.
The intolerance of milk-based products and stringent government regulation for clinical nutrition products might hamper the growth of the global clinical nutrition market
By product type
The global clinical nutrition market is segmented by type include infant nutrition, enteral nutrition, and parenteral nutrition. Infant nutrition dominates the clinical nutrition market in 2017, and it is expected to grow in the forecast period, due to the significant rise in infant malnutrition cases.
Acute malnutrition, chronic malnutrition, and overweight are three types of nutrition.
According to WHO, in 2017, 51 million children were suffering from acute malnutrition, 151 million children were suffering from chronic malnutrition, and 38 million children are suffering from being overweight.
Asia-Pacific dominates the global clinical nutrition market in 2017, and it is expected to grow in the forecast period, due to the high prevalence of malnutrition in children.
According to WHO, in Asia, 35 million children were suffering from acute malnutrition, 83.6 million children were suffering from chronic malnutrition, and 17.5 million children are suffering from overweight in 2017.
In 2017, Asia-pacific accounts for 55% of chronic malnutrition, 46% of overweight hunger, and 69% of acute malnutrition.
In 2017, in China 12.7 million children were suffering from chronic malnutrition.
Hence, the high prevalence of malnutrition in China will drive the Asia- Pacific clinical nutrition market.
The increasing new product launch and the expansion of the distribution network for clinical nutrition products in the market is expected to be a dominant strategy adopted by manufacturers to improve their market presence.
For instance, in July 2018, Nutrition, BASF’s nutrition brand has received EU Novel Food approval for 2’-fucosyllactose (2′-FL) and human milk oligosaccharide (HMO) for infant nutrition.
In June 2018, Abbott introduced Similac with HMO, infant formula in Vietnam.
Visualize the composition of the clinical nutrition market across each indication, regarding the product type, and by formulation highlighting the key commercial assets and players.
Identify business opportunities in the clinical nutrition market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the clinical nutrition market-level 4/5 segmentation
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
Product mapping in excel for the clinical nutrition products of all major market players.
Raw Material Suppliers/ Buyers
Product Suppliers/ Buyers
Industry Investors/Investment Bankers
1.1. Research Methodology
1.2. Scope of the market
2.1. Key Trends and Developments
3.3. Regulatory Scenario
3.4. Porter’s Five Forces Analysis
4.1. By Product Type
4.1.1. Infant Nutrition
4.1.2. Enteral Nutrition
126.96.36.199. Standard Nutrition
4.1.3. Parenteral Nutrition
188.8.131.52. Amino Acids
4.2. By Formulation
5.1. Geographic Overview
5.2. North America
5.3.4. Rest of Europe
5.4. South America
5.4.3. Rest of South America
5.5. Asia Pacific
5.5.5. Rest of Asia Pacific
5.6. Rest of World
6.1. Heat map Analysis
6.2. Brand Analysis
7.1. Nestle S.A
7.2. Abbott Laboratories
7.3. Baxter Healthcare Ltd.
7.4. Danone SA
7.5. B. Braun Melsungen AG
7.6. Fresenius Kabi AG
7.7. Mead Johnson & Company, LLC
7.8. Ajinomoto Co., Inc.
7.9. Nutricia Limited
7.10. Perrigo Company plc.
8.2. List of Tables
8.3. Expert Panel Validation
8.5. Contact Us
Get your free sample proposal with a single click!